• Cx43/NF-κB Pathway in AngII-Induced Macrophage Polarization

  2026-06-21

  This article analyzes recent findings on how Angiotensin II drives macrophage polarization toward the M1 phenotype via the connexin 43/NF-κB signaling pathway. The study provides mechanistic insights relevant to cardiovascular inflammation and highlights the functional consequences of targeting Cx43 hemichannels in immune modulation.

• Applied Use-Cases of Cholecystokinin Octapeptide Ammonium in

  2026-06-20

  Cholecystokinin octapeptide ammonium (CCK-8 ammonium) unlocks precise modulation of neurobehavioral, immunological, and cardiometabolic pathways, offering unique advantages for both in vitro and in vivo studies. This article bridges the latest mechanistic evidence with practical guidance, highlighting protocol optimization and troubleshooting for reproducible results.

• Docetaxel: Precision Oncology Insights Beyond Microtubule In

  2026-06-19

  Explore how Docetaxel advances cancer chemotherapy research by integrating microtubule inhibition with cellular heterogeneity analysis. This article offers unique, evidence-backed protocol guidance and reveals new opportunities for precision oncology.

• Anlotinib Hydrochloride: Multi-Target Tyrosine Kinase Inhibi

  2026-06-19

  Anlotinib hydrochloride streamlines angiogenesis and tumor research with potent, selective inhibition across VEGFR2, PDGFRβ, and FGFR1. Discover actionable workflows, troubleshooting tactics, and comparative data that position this APExBIO multi-target tyrosine kinase inhibitor as a gold standard for advanced cell-based assays.

• Dimethyloxalylglycine (DMOG): Technical Use and Protocol Gui

  2026-06-18

  Dimethyloxalylglycine (DMOG) enables controlled stabilization of hypoxia-inducible factor (HIF) by inhibiting prolyl-4-hydroxylase enzymes, making it indispensable for in vitro and in vivo modeling of hypoxia signaling and immune modulation. It should be used strictly for laboratory research—diagnostic or therapeutic applications are not supported.

• Translational Strategies Using Anlotinib Hydrochloride in An

  2026-06-18

  This article explores the mechanistic underpinnings, experimental validation, and translational trajectory of Anlotinib hydrochloride as a next-generation multi-target tyrosine kinase inhibitor for anti-angiogenic cancer research. Integrating recent preclinical evidence and practical workflow guidance, it provides strategic recommendations for researchers seeking to leverage this compound’s selectivity, safety, and translational promise.

• 25-Hydroxycholesterol Drives Immunosuppressive Macrophage Re

  2026-06-17

  Xiao et al. reveal that 25-hydroxycholesterol (25HC), produced via CH25H upregulation in tumor-associated macrophages (TAMs), accumulates in lysosomes and activates AMPKα, leading to STAT6-dependent immunosuppressive programming. This mechanistic insight positions CH25H as an immunometabolic checkpoint, with implications for re-educating TAMs and improving anti-tumor responses, particularly in combination with immune checkpoint blockade.

• TRIB3 Knockdown Sensitizes ccRCC to Sunitinib via Ferroptosi

  2026-06-17

  This study demonstrates that silencing TRIB3 enhances the sensitivity of clear cell renal cell carcinoma (ccRCC) to Sunitinib by promoting ferroptosis through the SLC7A11/GPX4 pathway. The findings offer a mechanistic basis for overcoming Sunitinib resistance in ccRCC and suggest new research strategies for targeting ferroptotic cell death in resistant tumors.

• Pulsed Plasma Degradation of Sulfamonomethoxine: Findings an

  2026-06-16

  This study demonstrates the effective degradation of sulfamonomethoxine (SMM) in aqueous solution using pulsed plasma discharge, revealing both the removal kinetics and the formation of transient by-products. The research highlights the environmental implications of plasma-generated hydrogen peroxide, emphasizing the need for further optimization to minimize ecotoxicity in water treatment applications.

• ATRX-Deficient Glioma Cells: Sensitivity to RTK Inhibition

  2026-06-16

  The referenced study identifies that ATRX-deficient high-grade glioma cells display increased vulnerability to multi-targeted receptor tyrosine kinase (RTK) and PDGFR inhibitors. This mechanistic insight supports the strategic use of RTK inhibitors in ATRX-mutant glioma models, with implications for both preclinical research and clinical trial design.

• Berberine Suppresses SASP Inflammation via RXRα/PPARγ/NEDD4

  2026-06-15

  This study reveals that berberine mitigates senescence-associated secretory phenotype (SASP)–driven inflammation in atherosclerosis by activating the RXRα/PPARγ/NEDD4 pathway in macrophage-derived foam cells. The research provides mechanistic clarity on how targeting this axis may offer new strategies for modulating chronic vascular inflammation and age-related cardiovascular disease.

• Ferrostatin-1 (Fer-1) in Translational Ferroptosis Research

  2026-06-15

  Explore how Ferrostatin-1 (Fer-1) reshapes ferroptosis research, offering deep insights into oxidative lipid damage inhibition and advanced disease modeling. This article uniquely bridges mechanistic science and assay innovation, with practical takeaways for cancer and neurodegeneration studies.

• Protease Inhibitor Cocktail EDTA-Free: Precision in Protein

  2026-06-14

  Preserve protein integrity in complex biological samples using APExBIO’s Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO). Unlock advanced workflows for phosphorylation-sensitive assays and troubleshoot common pitfalls with parameter-driven guidance.

• Gingerenone A Reverses Sunitinib Resistance in Renal Cell Ca

  2026-06-13

  This study reveals that gingerenone A, a phenolic compound from ginger, inhibits LDHA-driven glycolysis and restores sunitinib sensitivity in renal cell carcinoma (RCC) models. The findings highlight a metabolic co-targeting strategy to overcome resistance to multi-targeted receptor tyrosine kinase inhibitors in RCC research.

• GPR35-KLF5 Circuitry Directs Mucosal Repair in DSS Colitis M

  2026-06-12

  This study uncovers a tryptophan metabolic sensing mechanism in which GPR35 detects mucosal damage and activates KLF5-driven repair in intestinal epithelial cells. The findings clarify how epithelial cells decode injury signals, offering mechanistic insight for improving ulcerative colitis research and therapies using DSS-induced mouse models.

7981 records 8/533 page Previous Next First page 上5页 678910 下5页 Last page